文献速递肝病

机器学习方法实现NASH肝组织学定量测量与疾病监测

A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH.
PubMed 文献 · Hepatology · 2021-06-24

该研究利用三项随机对照试验的样本,构建并验证深度卷积神经网络,定量测量NASH关键组织学特征(脂肪变、炎症、气球样变和纤维化)。机器学习预测与专家病理学家强相关,并可预测肝硬化进展和肝脏相关临床事件;还开发了异质性敏感的纤维化治疗评估评分,检测到人工病理分期未发现的抗纤维化治疗效果。

要点

  • 机器学习可定量评估NASH组织学特征并与专家病理判读强相关。
  • 机器学习预测可预后肝硬化进展和肝脏相关临床事件。
  • 深度学习治疗评估肝纤维化评分能检测人工分期未发现的抗纤维化效应。

核心结论

  • 基于机器学习的肝组织学评估方法具有可重复性和敏感性,可预测NASH疾病进展,有助于理解疾病异质性、风险分层和疗法开发。

研究设计与样本

  • 研究使用三项随机对照试验的样本,构建并验证深度卷积神经网络以测量NASH关键组织学特征。

主要发现

  • 机器学习预测与专家病理学家强相关,并可预后进展至肝硬化和肝脏相关临床事件。
  • 深度学习治疗评估肝纤维化评分可测量人工病理分期未检测到的抗纤维化治疗效果,并与组织学疾病进展一致。

临床怎么用

  • 机器学习方法可用于NASH患者风险分层、监测治疗反应,并辅助识别传统病理分期可能漏判的抗纤维化效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Manual histological assessment is currently the accepted standard for diagnosing and monitoring disease progression in NASH, but is limited by variability in interpretation and insensitivity to change. Thus, there is a critical need for improved tools to assess liver pathology in order to risk stratify NASH patients and monitor treatment response. APPROACH AND RESULTS: Here, we describe a machine learning (ML)-based approach to liver histology assessment, which accurately characterizes disease severity and heterogeneity, and sensitively quantifies treatment response in NASH. We use samples from three randomized controlled trials to build and then validate deep convolutional neural networks to measure key histological features in NASH, including steatosis, inflammation, hepatocellular ballooning, and fibrosis. The ML-based predictions showed strong correlations with expert pathologists and were prognostic of progression to cirrhosis and liver-related clinical events. We developed a heterogeneity-sensitive metric of fibrosis response, the Deep Learning Treatment Assessment Liver Fibrosis score, which measured antifibrotic treatment effects that went undetected by manual pathological staging and was concordant with histological disease progression. CONCLUSIONS: Our ML method has shown reproducibility and sensitivity and was prognostic for disease progression, demonstrating the power of ML to advance our understanding of disease heterogeneity in NASH, risk stratify affected patients, and facilitate the development of therapies.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Taylor-Weiner A, Pokkalla H, Han L, et al. A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH. Hepatology. 2021. PMID: 33570776. doi:10.1002/hep.31750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。